Imbruvica Oral Capsule
Imbruvica (ibrutinib) is a member of the multikinase inhibitors drug class and is commonly used for Chronic Lymphocytic Leukemia, Graft-versus-host disease, Lymphoma, and others.
- Availability:In Stock
- Minimum Order:30 Capsules
What is Imbruvica?
Imbruvica (ibrutinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Imbruvica is used to treat mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, and small lymphocytic lymphoma. This medicine is also used to treat chronic graft-versus-host disease.
Imbruvica is usually given after other treatments have have not been effective.
Imbruvica was approved to treat mantle cell and marginal lymphomas by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some people responded to this medicine, but further studies are needed.
Imbruvica can make it easier for you to bleed. Contact your doctor or seek emergency medical attention if you have easy bruising, unusual bleeding, or any bleeding that will not stop. You may also have bleeding on the inside of your body, such as in your stomach or intestines, or in your brain.
Call your doctor at once if you have signs of bleeding inside your body, such as: dizziness, weakness, confusion, headache, speech problems, black or bloody stools, pink or brown urine, or coughing up blood or vomit that looks like coffee grounds.
Before taking this medicine
You should not use Imbruvica if you are allergic to ibrutinib.
To make sure this medicine is safe for you, tell your doctor if you have ever had:
an active infection;
a bleeding or blood clotting disorder;
a heart rhythm disorder; or
risk factors for heart disease (such as diabetes, smoking, being overweight, having high blood pressure or high cholesterol).
Using Imbruvica may increase your risk of developing other types of cancer, such as skin cancer. Ask your doctor about your specific risk.
Ibrutinib can harm an unborn baby. Both men and women using this medicine should use birth control to prevent pregnancy. The use of this medicine by either parent may cause harm to the baby.
Keep using birth control for at least 1 month after your last dose of Imbruvica. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using ibrutinib.
It may not be safe to breast-feed a baby while you are using this medicine. Ask your doctor about any risks.
Imbruvica side effects
Get emergency medical help if you have signs of an allergic reaction to Imbruvica: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using this medicine and call your doctor at once if you have:
signs of infection - fever, chills, weakness, mouth sores, cough with mucus, trouble breathing;
signs of bleeding inside your body - dizziness, weakness, confusion, problems with speech, prolonged headache, black or bloody stools, pink or brown urine, or coughing up blood or vomit that looks like coffee grounds;
severe or ongoing diarrhea;
chest pain, pounding heartbeats or fluttering in your chest, feeling like you might pass out;
easy bruising, unusual bleeding, purple or red spots under your skin;
pale skin, cold hands and feet;
kidney problems - little or no urinating, swelling in your feet or ankles; or
signs of tumor cell breakdown - confusion, weakness, muscle cramps, nausea, vomiting, fast or slow heart rate, decreased urination, tingling in your hands and feet or around your mouth.
Common Imbruvica side effects may include:
fever, cough, trouble breathing;
blisters or ulcers in your mouth;
bruising, rash; or
muscle pain, bone pain.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
Your email address will not be published.